Yonsei University is partnering with RIKEN and IBM to utilize the world's top-level supercomputer, Fugaku, and IBM Quantum System One to tackle complex computational challenges in understanding diseases like Leigh Syndrome.
Yonsei University, under President Yoon Dong-seob, has embarked on a groundbreaking computational project in collaboration with RIKEN (the RIKEN Center for Computational Science in Japan) and IBM. They aim to integrate the exceptional supercomputer Fugaku with the IBM Quantum System One at Yonsei University. This project targets complex biological phenomena that existing traditional computing methods cannot adequately solve. One of the primary focuses is understanding Leigh Syndrome, a severe mitochondrial disorder that leads to early infant mortality due to energy production failures in cells. Understanding this disease's mechanisms is critical, as it demands extraordinary computational resources, specifically to evaluate expansive matrices requiring calculations that no current supercomputer can achieve rapidly enough.
The project is significant not only for its scientific ambitions but also for its technological achievements in creating physical and technical links between gigantic computational resources across institutions. RIKEN has already succeeded in connecting its supercomputer with IBM's Quantum System Two, scheduled for June 2025. This connectivity opens avenues for new research paradigms by allowing for unprecedented collaboration among global scientific communities. Furthermore, the partnership aims to enhance quantum algorithms applicable to biomedicine, demonstrating the move towards a more interconnected scientific approach that transcends national and disciplinary boundaries.
In summary, the collaboration between Yonsei University, RIKEN, and IBM stands to revolutionize how complex biological issues are tackled using quantum computing. As researchers face the immense computational challenges posed by diseases like Leigh Syndrome, this initiative positions itself at the forefront of combing quantum computing power with medical research, potentially leading to groundbreaking discoveries in the near future. The implications are profound, not only for the treatment of mitochondrial diseases but also for the future of computational biology, opening new pathways for interdisciplinary research and innovation in healthcare.
